BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06236438-completion@plaintrial.com
DTSTAMP:20261030T115557Z
DTSTART;VALUE=DATE:203110
SUMMARY:Study to Evaluate Adverse Events\, Optimal Dose\, and Change in Dis
 ease Activity\, With Livmoniplimab in Combination With Budigalimab Plus Ch
 emotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Part
 icipants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer
  (NSCLC) — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06236438
URL:https://plaintrial.com/trial/NCT06236438
END:VEVENT
END:VCALENDAR